Katharina L Kopp
Overview
Explore the profile of Katharina L Kopp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
627
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lecoq I, Kopp K, Chapellier M, Mantas P, Martinenaite E, Perez-Penco M, et al.
Oncoimmunology
. 2022 Sep;
11(1):2115655.
PMID: 36052217
CCL22 is a macrophage-derived immunosuppressive chemokine that recruits regulatory T cells through the CCL22:CCR4 axis. CCL22 was shown to play a key role in suppressing anti-cancer immune responses in different...
2.
Dey S, Sutanto-Ward E, Kopp K, DuHadaway J, Mondal A, Ghaban D, et al.
J Immunother Cancer
. 2020 Jul;
8(2).
PMID: 32690770
Background: The tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase 1 (IDO1), which subverts T-cell immunity at multiple levels, is itself subject to inherent T-cell reactivity. This intriguing deviation from central tolerance has been...
3.
Pedersen A, Kopp K, Andersen M, Zocca M
Chin Clin Oncol
. 2018 May;
7(2):19.
PMID: 29764164
Historically, the development of cancer vaccines has focused on the central role of tumor antigens in eliciting tumor-specific immune responses, with limited success. Recent advances with checkpoint blockade approaches have...
4.
Fredholm S, Willerslev-Olsen A, Met O, Kubat L, Gluud M, Mathiasen S, et al.
J Invest Dermatol
. 2018 May;
138(8):1805-1815.
PMID: 29751003
Deficient expression of SATB1 hampers thymocyte development and results in inept T-cell lineages. Recent data implicate dysregulated SATB1 expression in the pathogenesis of mycosis fungoides, the most frequent variant of...
5.
Sibbesen N, Kopp K, Litvinov I, Jonson L, Willerslev-Olsen A, Fredholm S, et al.
Oncotarget
. 2015 Aug;
6(24):20555-69.
PMID: 26244872
Aberrant activation of Janus kinase-3 (Jak3) and its key down-stream effectors, Signal Transducer and Activator of Transcription-3 (STAT3) and STAT5, is a key feature of malignant transformation in cutaneous T-cell...
6.
Lauenborg B, Christensen L, Ralfkiaer U, Kopp K, Jonson L, Dabelsteen S, et al.
Oncotarget
. 2015 Apr;
6(17):15235-49.
PMID: 25915535
Lymphotoxin α (LTα) plays a key role in the formation of lymphatic vasculature and secondary lymphoid structures. Cutaneous T cell lymphoma (CTCL) is the most common primary lymphoma of the...
7.
Radhakrishnan P, Dabelsteen S, Madsen F, Francavilla C, Kopp K, Steentoft C, et al.
Proc Natl Acad Sci U S A
. 2014 Aug;
111(39):E4066-75.
PMID: 25118277
Aberrant expression of immature truncated O-glycans is a characteristic feature observed on virtually all epithelial cancer cells, and a very high frequency is observed in early epithelial premalignant lesions that...
8.
Kopp K, Ralfkiaer U, Nielsen B, Gniadecki R, Woetmann A, Odum N, et al.
APMIS
. 2013 Sep;
121(11):1020-4.
PMID: 24033365
Recently, miR-155 has been implicated in cutaneous T-cell lymphoma (CTCL). Thus, elevated levels of miR-155 were observed in skin lesions from CTCL patients as judged from qPCR and micro-array analysis...
9.
Krejsgaard T, Litvinov I, Wang Y, Xia L, Willerslev-Olsen A, Koralov S, et al.
Blood
. 2013 Jun;
122(6):943-50.
PMID: 23801634
Inappropriately regulated expression of interleukin (IL)-17A is associated with the development of inflammatory diseases and cancer. However, little is known about the role of other IL-17 family members in carcinogenesis....
10.
Marstrand T, Ahler C, Ralfkiaer U, Clemmensen A, Kopp K, Sibbesen N, et al.
Leuk Lymphoma
. 2013 Jun;
55(4):957-8.
PMID: 23772646
No abstract available.